Astrazeneca (AZN): Rep. Alan S. Lowenthal (CA47) disclosed a purchase $1K–$15K
Rep. Alan S. Lowenthal (CA47) disclosed a purchase of Astrazeneca in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 11 days
- Disclosure lag
- Traded
- Feb 22, 2021
- Disclosed
- Mar 5, 2021
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 22, 2021 · this disclosureCongressDisclosed purchase of AZN — reported range $1,001 - $15,000
What came next
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Astrazeneca
For Astrazeneca, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AZN page.
Other recent filings by Rep. Alan S. Lowenthal (CA47)
- House Clerk periodic transaction report at Salesforce (CRM)Dec 21, 2022
- House Clerk periodic transaction report at Salesforce (CRM)Dec 21, 2022
- House Clerk periodic transaction report at Blackstone Inc. (BX)Nov 23, 2022
- House Clerk periodic transaction report at TJX Companies (TJX)Nov 23, 2022
- House Clerk periodic transaction report at T-Mobile (TMUS)Nov 23, 2022
The full history of Rep. Alan S. Lowenthal (CA47) is on the profile page.
How this filing works
Explore the data
Other disclosures at Astrazeneca
- SEC Form 13F-HRAug 25, 2026
- SEC Form 13F-HRAug 18, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its AZN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data